Skip to main content
SpringerLink
Log in

Neural Regulation of Allergy and Asthma. The Discoveries and Seminal Contributions of Andor Szentivanyi

  • Chapter
Book cover Advances in Psychoneuroimmunology

Part of the book series: Hans Selye Symposia on Neuroendocrinology and Stress ((HSSN,volume 3))

  • 62 Accesses

Abstract

The aspirations of natural sciences are to discover and understand the laws of Mother Nature with the final goal of diminishing human suffering and maintaining human activity in harmony with our environment. The presentation of facts pertinent to establishing natural laws is the overwhelming consideration in the literature of natural sciences and the human and social factors seldom get presented even though they play a major role in the evolution of science. I often wonder what it was like to state for the first time that the earth is not the center of the universe, or that God did not create man, but human beings are the result of a process of evolution from simple organisms to more complicated ones, or to uncover that diseases may be caused by invisible microorganisms, just to mention a few of the major advances in natural sciences. Perhaps one can rephrase this question. How many people recognized that the earth is moving but were afraid to say so either because they did not trust their own judgement or, perhaps, because they were afraid of punishment for heretic thinking. In the Middle Ages, heretic thinking was punishable by death so it took an extreme amount of courage on the part of Galilei to publicize his discovery. Why did he do it? One can only resort to guesses to outline his reasons. First of all, he must have been absolutely convinced that the evidence that he found was sufficient to prove his point. Second, he must have trusted his judgement and was not discouraged from publicizing his conclusion by the possibility that no one would agree with him.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. G. Filipp, A. Szentivanyi and B. Mess, Anaphylaxis and nervous system, Acta Med. Hung. Tomus III, Fasciculus 2:163 (1952).

    Google Scholar 

  2. A. Szentivanyi and G. Filipp, Anaphylaxis and the nervous system. Part II, Ann. Allergy 16:143 (1958).

    PubMed  CAS  Google Scholar 

  3. G. Filipp and A. Szentivanyi, Anaphylaxis and the nervous system. Part III, Ann. Allergy 16:306 (1958).

    PubMed  CAS  Google Scholar 

  4. A. Szentivanyi and J. Szekely, Effect of injury to, and electrical stimulation of, hypothalamic areas on anaphylactic and histamine shock of the guinea pig. A preliminary report, Ann. Allergy 14:259 (1956).

    PubMed  CAS  Google Scholar 

  5. A. Szentivanyi and J. Szekely, Anaphylaxis and the nervous system. Part IV, Ann. Allergy 16:389 (1958).

    PubMed  CAS  Google Scholar 

  6. A. Szentivanyi, C.W. Fishel and D.W. Talmage, Adrenaline mediation of histamine and serotonin hyperglycemia in normal mice and the absence of adrenaline-induced hyperglycemia in pertussis-sensitized mice, J. Infect. Dis. 113:86 (1963).

    Article  PubMed  CAS  Google Scholar 

  7. C.W. Fishel and A. Szentivanyi, The absence of adrenaline-induced hyperglycemia in pertussis-sensitized mice and its relation to histamine and serotonin hypersensitivity, J. Allergy 34:439 (1963).

    Article  PubMed  CAS  Google Scholar 

  8. R.G. Townley, I.L. Trapani and A. Szentivanyi, Sensitization to anaphylaxis and to some of its pharmacological mediators by blockade of the beta adrenergic receptors, J. Allergy 39:177 (1967).

    Article  PubMed  CAS  Google Scholar 

  9. A. Szentivanyi, The beta adrenergic theory of the atopic abnormality in bronchial asthma, J. Allergy 42:203 (1968).

    Article  Google Scholar 

  10. S. Katsh, D.G. Halkias and A. Szentivanyi, Analysis of the structural requirements for the histamine-sensitizing activity of the beta adrenergic blocking agents, J. Allergy 43:171 (1969).

    Google Scholar 

  11. A. Szentivanyi, The conformational flexibility of adrenoceptors and the constitutional basis of atopy, Triangle 18:109 (1979).

    PubMed  CAS  Google Scholar 

  12. A. Szentivanyi, O. Heim and P. Schultze, Changes in adrenoceptor densities in membranes of lung tissue and lymphocytes from patients with atopic disease, Ann. N.Y. Acad. Sci. 332:295 (1979).

    Article  PubMed  CAS  Google Scholar 

  13. A. Szentivanyi, P. Schultze, O. Heim, J. Szentivanyi and J.B. Poison, Two different patterns of adrenoceptor mechanisms in drug versus disease-induced beta adrenergic subsensitivity in membranes of T and B lymphocytes, J. Reticuloendoth. Soc. 26:291 (1979).

    Google Scholar 

  14. A. Szentivanyi, La flexibilite de conformation des adrenocepteurs et la base constitutionelle du terrain allergique, Rev. Franc. Allergol. 19:205 (1979).

    Google Scholar 

  15. A. Szentivanyi, J. Szentivanyi and H. Wagner, Measurement of numbers of adrenoceptors in lymphocytes and lung tissue of patients with reversible obstructive airways disease, Clin. Pharmacol. Titer. 27:193 (1980).

    Google Scholar 

  16. A. Szentivanyi, O. Heim, P. Schultze and J. Szentivanyi, Adrenoceptor binding studies with [3H] dihydroalprenolol with [H] dihydroergocryptine on membranes of lymphocytes from patients with atopic disease, Acta Dermato-Venerol. Suppl. 92:19 (1980).

    Google Scholar 

  17. S. Asai, J.J. Krzanowski, D.F. Martin, R.F. Lockey, S.C. Bukantz and A. Szentivanyi, Ptychodiscus brevis toxin stimulates a new receptor site in activating parasympathetic nerve axonal voltage-sensitive sodium channels, J. Allergy Clin. Immunol. 69:10 (1982).

    Article  Google Scholar 

  18. A. Szentivanyi, Adrenergic receptors, Int. J. Immunoparmacol. 4:292 (1982).

    Google Scholar 

  19. A. Szentivanyi and J. Szentivanyi, Altered adrenoceptor function in disease states, Pathobiol Anna. 12:340 (1982).

    Google Scholar 

  20. A. Szentivanyi and J. Szentivanyi, Some selected aspects of the immunopharmacology of adrenoceptors, Adv. Immunopharmacol. 2:269 (1983).

    Google Scholar 

  21. J.B. Poison, R.F. Lockey, S.C. Bukantz, S. Lowitt, J.J. Krzanowski and A. Szentivanyi, Effects of ketotifen on the responsiveness of human peripheral blood lymphocyte beta adrenergic receptors, The Pharmacologist 29:132 (1987).

    Google Scholar 

  22. J.B. Poison, R.F. Lockey, S.C. Bukantz, S. Lowitt, J.J. Krzanowski and A. Szentivanyi, Responsiveness of lymphocyte beta adrenergic receptors in patients treated with ketotifen, Clin. Pharmacol. Tlierap. 43:137 (1988).

    Google Scholar 

  23. J.B. Poison, R.F. Lockey, S.C. Bukantz, S. Lowitt, J.J. Krzanowski and A. Szentivanyi, Effects of ketotifen on the responsiveness of peripheral blood lymphocyte beta adrenergic receptors, Int. J. Immunopharmacol. 10:657 (1988).

    Article  Google Scholar 

  24. J.J. Krzanowski, M.E. Schwartz, S. Reiner, O. Heim, C. Abarca and A. Szentivanyi, Adrenergic influences on the induction of histidine decarboxylase synthesis in hematopoietic progenitor cells, J. Leukocyte Biol. 46:294 (1989).

    Google Scholar 

  25. A. Szentivanyi, M.E. Schwartz, O. Heim, G. Filipp and C. Abarca, Ketotifen treatment restores the beta adrenergic modulation of the N-formylmethionyl-leucyl-phenylalanine (FMLP) induced respiratory burst in polymorphonuclear leukocytes (PMN) in asthma, J. Clin. Pharmacol. 29:859 (1989).

    Google Scholar 

  26. A. Szentivanyi, M.E. Schwartz, S. Reiner, O. Heim, C. Abarca, S. Robicsek and J.J. Krzanowski, Requirements for central and peripheral adrenergic input in the induction of histidine decarboxylase synthesis by interleukin 3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) in hematopoietic progenitor cells, Cytokine 1:133 (1989).

    Google Scholar 

  27. A. Szentivanyi, S. Reiner, M.E. Schwartz, O. Heim, J. Szentivanyi and S. Robicsek, Restoration of normal beta adrenoceptor concentrations in A549 lung adenocarcinoma cells by leukocyte protein factors and recombinant interleukin-1a (IL-1a), Cytokine 1:118 (1989).

    Google Scholar 

  28. G. Kunkel, R. Paus, J.B. Poison and A. Szentivanyi, Beta-adrenergic receptors in nasal tissue with reference to their role in asthma and atopy, Allergol Immunopathol 17:67 (1989).

    CAS  Google Scholar 

  29. A. Szentivanyi, S. Reiner, O. Heim, S. Robicsek and J.F. Hackney, Studies on the nature of the lymphocytic protein factors upregulating beta-adrenergic receptors, Clin. Pharmacol. Therap. 149:139 (1991).

    Google Scholar 

  30. A. Szentivanyi, P. Schultze, O. Heim, S. Reiner, S. Robicsek, J. Zority, K.J. Hurt, J.F. Hackney, E.G. Calderón, J.J. Dwornik and R.F. Lockey, The elution profile of the A549 beta adrenergic (bAR) regulating activity of lymphocyte conditioned medium (LCM) of IM9 cells developed by DEAE ion exchange HPLC, Int. J. Immunopharmacol. 13:68 (1991).

    Google Scholar 

  31. A. Szentivanyi, E.G. Calderón, O. Heim, P. Schultze, H. Wagner, J. Zority, R.F. Lockey, J.J. Dwornik and S. Robicsek, Adrenergic and histamine receptor concentrations in bone marrow cells, Int. J. Immunopharmacol 13:740 (1991).

    Google Scholar 

  32. A. Szentivanyi, O. Heim, P. Schultze, H. Wagner, J. Zority, E. Calderón, J.J. Dwornik and R.F. Lockey, Sensitization of bone marrow hemopoietic progenitor cells to the interleukin-3 (IL-3) and granulocyte macrophage colony stimulating factor (GM-CSF) induced de novo synthesis of histidine decarboxylase through the activation of beta adrenoceptors, Int. J. Immunopharmacol. 13:73 (1991).

    Article  Google Scholar 

  33. J. Szentivanyi, S. Reiner, O. Heim, J.F. Hackney, S. Robicsek, R.F. Lockey, J.J. Dwornik and A. Szentivanyi, Impaired capacity of lymphocyte proteins to upregulate beta-adrenoceptors in A549 human lung adenocarcinoma cells in respiratory and cutaneous atopic disease, Int. J. Immunopharmacol. 13:743 (1991).

    Google Scholar 

  34. E.G. Calderón, O. Heim, A. Szentivanyi, P. Schultze, H. Wagner, J. Zority, R.F. Lockey, J.J. Dwornik and S. Robicsek, Adrenergic and histamine receptor concentrations in bone marow cells, J. Allergy Clin. Immunol. 89:277 (1992).

    Article  Google Scholar 

  35. R.A. Ortez, T.W. Klein and A. Szentivanyi, Impairment of the adenyl cyclase system in spleens of mice sensitized bacterially or by beta pharmacological blockade, J. Allergy 45:111 (1970).

    Google Scholar 

  36. R.A. Ortez, T.W. Klein and A. Szentivanyi, Cyclic AMP levels in spleens of pertussis-sensitized mice, Fed. Proc. 29:640 (1970).

    Google Scholar 

  37. J.J. Krzanowski, J.B. Poison and A. Szentivanyi, Histamine, isoproterenol, and epinephrine induced in vivo activation of adenyl cyclase in mouse lung following Bordetella pertussis, The Pharmacologist 16:212 (1974).

    Google Scholar 

  38. J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Effects of methacholine, histamine, and atropine on pulmonary guanosine-3′,5′-cyclic monophosphate in hypersensitive mice, The Pharmacologist 16:212 (1974).

    Google Scholar 

  39. J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Histamine-induced changes in pulmonary guanosine-3′,5′-cyclic monophosphate and adenosine-3′,5′-cyclic monophosphate levels in mice following sensitization by Bordetella pertussis and/or propranolol, Res. Commun. Chem. Pathol. Pharmacol. 9:243 (1974).

    Google Scholar 

  40. J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Elevation of pulmonary cyclic GMP levels caused by histamine and methacholine in mice simulating atopic disease, Adv. Cyclic Nucleotide Res. 5:815 (1974).

    Google Scholar 

  41. J.J. Krzanowski, J.B. Poison and A. Szentivanyi, In vivo alterations in adenosine-3′,5,-cyclic monophosphate levels following adrenergic activation in animal models of atopic disease, Adv. Cyclic Nucleotide Res. 5:819 (1975).

    Google Scholar 

  42. J.J. Krzanowski, J.B. Poison and A. Szentivanyi, Pulmonary patterns of adenosine-3′,5′-cyclic monophosphate accumulations in response to adrenergic or histamine stimulation in Bordetella pertussis-sensitized mice, Biochem. Pharmacol. 25:1631 (1976).

    Article  PubMed  CAS  Google Scholar 

  43. J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Pulmonary guanosine-3′,5′-cyclic monophosphate in sensitized mice: Accumulations produced by H-l receptor activation and evidence of altered phosphodiesterase activity, J. Allergy Clin. Immunol. 57:265 (1976).

    Google Scholar 

  44. JJ. Krzanowski, J.B. Poison and A. Szentivanyi, Reduction in levels of pulmonary cyclic guanosine-3′,5′,-monophosphate induced by theophylline and isoproterenol, J. Allergy Clin. Immunol. 57:265 (1976).

    Google Scholar 

  45. D.F. Fitzpatrick and A. Szentivanyi, The effects of protein kinase and cyclic nucleotides on calcium (Ca2+) uptake by rabbit aortic microsomes, The Pharmacologist 18:182 (1976).

    Google Scholar 

  46. A.L. Goldman, T.A. Ebel, J.J. Krzanowski, J.B. Poison and A. Szentivanyi, Lung cyclic nucleotides in bronchospastic and nonreversible obstructive lung disease, Am. Rev. Resp. Dis. 115:330 (1977).

    Google Scholar 

  47. J.J. Krzanowski, J.B. Poison and A. Szentivanyi, Pulmonary cyclic nucleotide lowering after ganglionic blockade and prostaglandin synthetase inhibition, The Pharmacologist 19:204 (1977).

    Google Scholar 

  48. D.F. Fitzpatrick and A. Szentivanyi, Stimulation of calcium uptake into aortic microsomes by cyclic AMP and cyclic AMP-dependent protein kinase, Naun. Schmied. Arch. Pharmacol. 298:255 (1977).

    Article  CAS  Google Scholar 

  49. J.J. Krzanowski, J.B. Poison, A.L. Goldman, T.A. Ebel and A. Szentivanyi, Cyclic nucleotide levels in human lung from patients with bronchospastic airway disease, The Pharmacologist 19:203 (1977).

    Google Scholar 

  50. J.B. Poison, J.J. Krzanowski, D.F. Fitzpatrick and A. Szentivanyi, Studies on the inhibition of phosphodiesterase-catalyzed cyclic AMP and cyclic GMP breakdown and relaxation of canine tracheal smooth muscle, Biochem. Pharmacol. 27:254 (1978).

    Article  Google Scholar 

  51. J.B. Poison, J.J. Krzanowski, A.L. Goldman, T.A. Ebel and A. Szentivanyi, Cyclic nucleotide phosphodiesterase activity in patients with reversible and nonreversible airway obstruction, Adv. Cyclic Nucleotide Res. 9:757 (1978).

    Google Scholar 

  52. J.J. Krzanowski, J.B. Poison, A.L. Goldman, T.A. Ebel and A. Szentivanyi, Cyclic nucleotide levels in human lung from patients with bronchospastic airway disease, Adv. Cyclic Nucleotide Res. 9:767 (1978).

    Google Scholar 

  53. J.J. Krzanowski, J.B. Poison, A.L. Goldman, T.A. Ebel and A. Szentivanyi, Reduced adenosine 3′,5′-cyclic monophosphate levels in patients with reversible obstructive airways disease, Clin. Exp. Pharmacol. Physiol. 6:111 (1979).

    Article  PubMed  CAS  Google Scholar 

  54. J.J. Krzanowski, J.B. Poison and A. Szentivanyi, Divergent effects of prostaglandin synthesis inhibitors on pulmonary cyclic 3′,5′,-adenosine monophosphate and cyclic 3′,5′-guanosine monophosphate levels in untreated and histamine-sensitized mice, Arch. Int. Pharmacodyn. 241:324 (1979).

    PubMed  CAS  Google Scholar 

  55. J.J. Krzanowski, A. Urdaneta-Bohorquez, J.B. Poison, Y. Sakamoto and A. Szentivanyi, Studies of two smooth muscle relaxants (adenosine and theophylline) both capable of influencing tissue cyclic AMP levels on canine tracheal smooth muscle, Adv. Cyclic Nucleotide Res. 17A:49 (1984).

    Google Scholar 

  56. R.A. Duncan, J.J. Krzanowski, J.S. Davis, J.B. Poison, R.G. Coffey, T. Shimoda and A. Szentivanyi, Polyphosphoinositide metabolism in canine tracheal smooth muscle in response to a cholinergic stimulus, Biochem. Pharmacol. 36:307 (1987).

    Article  PubMed  CAS  Google Scholar 

  57. R. Duncan, J.J. Krzanowski, J. Poison, J.B. Coffey, T. Shimoda and A. Szentivanyi, The kinetics of the acetylcholine induced inositol phosphate formation in isolated contracting canine tracheal smooth muscle, J. Allergy Clin. Immunol. 79:196 (1987).

    Google Scholar 

  58. J.J. Krzanowski, A. Urdaneta-Bohorquez, J.B. Poison, Y. Sakamoto and A. Szentivanyi, Effects of adenosine and theophylline on canine tracheal smooth muscle tone, Arch. Int. Pharmacodyn. Ther. 287:224 (1987).

    PubMed  CAS  Google Scholar 

  59. R.A. Duncan, J.J. Krzanowski, J. Davis, R.G. Coffey, J.B. Poison, T. Watanabe and A. Szentivanyi, The dose-response relationship between inositol phosphate formation and contractile resposnes in canine tracheal smooth muscle, The Pharmacologist 29:117 (1987).

    Google Scholar 

  60. J.J. Krzanowski, J.B. Poison and A. Szentivanyi, Theophylline attenuation of histamine-induced increases in pulmonary adenosine-3′,5′,-cyclic monohosphate, J. Allergy Clin. Immunol. 55:133 (1975).

    Google Scholar 

  61. J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Theophylline, theobromine and caffeine inhibition of cAMP and cGMP hydrolysis by respiratory smooth muscle phosphodiesterase, J. Allergy Clin. Immunol. 55:133 (1975).

    Google Scholar 

  62. J.B. Poison and A. Szentivanyi, Theophylline, theobromine, caffeine, and ICI 58,301 inhibition of adenosine-3′,5′-cyclic phosphate and guanosine-3′,5′-cyclic phosphate hydrolysis by canine tracheal smooth muscle phosphodiesterase, Fed. Proc. 34:261 (1975).

    Google Scholar 

  63. J.J. Krzanowski, A. Szentivanyi and D.B. Tyler, Reduction of the histamine-induced increase in pulmonary adenosine-3′,5′-cyclic monophosphate levels by theophylline, Fed. Proc. 34:332 (1975).

    Google Scholar 

  64. D.F. Fitzpatrick, J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Correlation of tracheal smooth muscle relaxation with phosphodiesterase inhibition, Vie Pharmacologist 17:271 (1975).

    Google Scholar 

  65. J.F. Williams, J.B. Poison and A. Szentivanyi, Investigation of the pharmacological activity of the matabolites of the methylxanthines, The Pharmacologist 18:181 (1976).

    Google Scholar 

  66. J.B. Poison, J.J. Krzanowski, A.L. Goldman, T.A. Ebel and A. Szentivanyi, inhibition of human pulmonary phosphodiesterase by therapeutic levels of theophylline, The Pharmacologist 19:203 (1977).

    Google Scholar 

  67. J.F. Williams, S. Lowitt, J.B. Poison and A. Szentivanyi, Pharmacological and biochemical activities of some monomethylxanthine and methyluric acid derivatives of theophylline and caffeine, Biochem. Pharmacol. 27:1545 (1978).

    Article  PubMed  CAS  Google Scholar 

  68. J.B. Poison, J.J. Krzanowski, A.L. Goldman and A. Szentivanyi, Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline, Clin. Exp. Pharmacol. Physiol. 5:553 (1978).

    Article  Google Scholar 

  69. J.P. Poison, J.J. Krzanowski, W.H. Anderson, D.F. Fitzpatrick, D.P.C. Hwang and A. Szentivanyi, Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle, Biochem. Pharmacol. 28:1391 (1979).

    Article  Google Scholar 

  70. J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Stimulation of cyclic AMP phosphodiesterase activity by the heated supernatant fraction of canine tracheal smooth muscle, Allergol. Immunopathol. 7:297 (1979).

    Google Scholar 

  71. J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Separation of the cyclic nucleotide phosphodiesterase of canine tracheal smooth muscle, Fed. Proc. 40:665 (1981).

    Google Scholar 

  72. J.B. Poison, J.J. Krzanowski, A.L. Goldman and A. Szentivanyi, Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease, Allergol. Immunopathol. 10:101 (1982).

    Google Scholar 

  73. J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Inhibition of a high affinity cyclic AMP phosphodiesterase and relaxation of canine tracheal smooth muscle, Biochem. Pharmacol 31:3403 (1982).

    Article  Google Scholar 

  74. J.J. Krzanowski, J.B. Poison, M. McPherson, A. Urdaneta-Bohorquez and A. Szentivanyi, Adenosine-theophylline interactions in canine tracheal smooth muscle strips, J. Allergy Clin. Immunol. 71:131 (1983).

    Article  Google Scholar 

  75. J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Cyclic nucleotide phosphodiesterases partially purified from canine tracheal smooth muscle, Adv. Cyclic Nucleotide Res. 17A:41 (1984).

    Google Scholar 

  76. J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Correlation between inhibition of a cyclic GMP phosphodiesterase and relaxation of canine tracheal smooth muscle, Biochem. Pharmacol. 34:1875 (1985).

    Article  Google Scholar 

  77. S. Robicsek, J.B. Poison, J.J. Krzanowski, R.F. Lockey and A. Szentivanyi, Study of human lymphocyte phosphodiesterase using high pressure liquid chromatography, J. Allergy Clin. Immunol. 79:168 (1987).

    Google Scholar 

  78. S. Robicsek, J.B. Poison, J.J. Krzanowski, R.F. Lockey and A. Szentivanyi, High pressure liquid chromatography of human T-lymphocyte phosphodiesterases, Clin. Pharmacol. Ther. 43:167 (1988).

    Google Scholar 

  79. S. Robicsek, J.B. Poison, J.J. Krzanowski, R.F. Lockey and A. Szentivanyi, Separation of lymphocyte cyclic nucleotide phosphodiesterases by ion exchange high pressure liquid chromatography, Adv. Sec. Mess. Phosphopro. Res. 21A:24 (1988).

    Google Scholar 

  80. S. Robecsek, J.J. Krzanowski, A. Szentivanyi and J.B. Poison, Analysis of human T-lymphocyte cyclic nucleotide phosphodiesterase activity by high pressure liquid chromatography and type III inhibitors, FASEB J. 3:1295 (1989).

    Google Scholar 

  81. J.B. Poison, SA. Robicsek, J.J. Krzanowski and A. Szentivanyi, Paritculate cyclic AMP phosphodiesterase in human T-lymphocytes, Clin. Pharmacol. Ther. 47:169 (1990).

    Google Scholar 

  82. S. Robicsek, D.K. Blanchard, J. Djeu, J.J. Krzanowski, A. Szentivanyi and J.B. Poison, Attenuation of human T-lymphocyte blastogenesis by the selective inhibition of cAMP-phosphodiesterases, FASEB J. 4:A337 (1990).

    Google Scholar 

  83. S. Robicsek, D.K. Blanchard, J. Djeu, J.J. Krzanowski, A. Szentivanyi and J.B. Poison, Synergistic effect on T-lymphocyte blastogenesis by selective cAMP-phosphodiesterase inhibitors, FASEB J. 4:2036 (1990).

    Google Scholar 

  84. S.A. Robicsek, D.K. Blanchard, J.Y. Djeu, J.J. Krzanowski, A. Szentivanyi and J.B. Poison, Multiple high affinity cAMP-phosphodiesterases regulate proliferation in human thymic lymphocytes, Biochem. Pharmacol. 42:869 (1991).

    Article  PubMed  CAS  Google Scholar 

  85. S. Robicsek, D.K. Blanchard, J. Djeu, J.J. Krzanowski, A. Szentivanyi and J.B. Poison, Attenuation of IL-2 and Tac receptor expression by selective PDE inhibitors in human T-lymphocytes, Int. J. Immunophartnacol. 13:734 (1991).

    Google Scholar 

  86. R.A. Ortez, C.W. Fishel and A. Szentivanyi, The reduced sensitivity of Bordetella pertussis vaccinated murine spleen and platelet adenyl cyclase to epinephrine, Fed. Proc. 31:748 (1972).

    Google Scholar 

  87. C.W. Fishel, A. Szentivanyi and T.W. Klein, Effect of epinephrine on plasma cyclic adenosine monophosphate levels of Bordetella pertussis-vaccinated and of adrenergically blocked mice, Fed. Proc. 32:1009 (1973).

    Google Scholar 

  88. J.B. Poison, J.J. Krzanowski and A. Szentivanyi, Effect of histamine on the pulmonary levels of cyclic nucleotides in normal mice and under conditions of pharmacologic or bacterial sensitization, J. Allergy Clin. Immunol. 53:100 (1974).

    Google Scholar 

  89. J.J. Krzanowski, J.B. Poison and A. Szentivanyi, Energy mtabolism and patterns of behavior of adenosine-3′,5′,-cyclic monophosphate in lung from control and bacterially sensitized mice under conditions of rest and adrenergic activation, J. Allergy Clin. Immunol. 53:100 (1974).

    Google Scholar 

  90. T.W. Klein, A. Szentivanyi and C.W. Fishel, Effects of serotonin on platelets of normal and Bordetella pertussis-injected mice, Proc. Soc. Exp. Biol Med. 147:681 (1974).

    PubMed  CAS  Google Scholar 

  91. R.A. Ortez, D. Seshachalam and A. Szentivanyi, Alterations in adenyl cyclase activity and glucose utilization of Bordetella pertussis sensitized mouse spleen, Biochem. Pharmacol. 24:1297 (1975).

    Article  PubMed  CAS  Google Scholar 

  92. J.F. Williams and A. Szentivanyi, Effect of Bordetella pertussis vaccine on the drug-metabolizing enzyme system of mouse liver, Fed. Proc. 34:261 (1975).

    Google Scholar 

  93. C.W. Fishel, D.G. Halkias, T.W. Klein and A. Szentivanyi, Characteristics of cells present in peritoneal fluids of mice injected intraperitoneally with Bordetella pertussis, Infect. Immun. 13:263 (1976).

    PubMed  CAS  Google Scholar 

  94. J.F. Williams and A. Szentivanyi, Depression of hepatic drug-metabolizing enzyme activity by Bordetella pertussis vaccination, Eur. J. Pharmacol. 43:281 (1977).

    Article  PubMed  CAS  Google Scholar 

  95. J.F. Williams, S. Lowitt and A. Szentivanyi, Effect of endotoxin and phenobarbital on heme enzymes of rat liver, The Pharmacologist 21:232 (1979).

    Google Scholar 

  96. J.F. Williams, S. Lowitt and A. Szentivanyi, Involvement of a heat-stable and heat-1abile component of Bordetella pertussis in the depression of murine hepatic mixed-function oxidase system, Biochem. Pharmacol. 29:1483 (1980).

    Article  PubMed  CAS  Google Scholar 

  97. J.F. Williams, S. Lowitt and Z. Szentivanyi, Endotoxin depression of hepatic mixed function oxidase system in C3H/Hej and C3H/H3N mice, Immunopharmocology 2:285 (1980).

    Article  CAS  Google Scholar 

  98. J.F. Williams, A.L. Winters, S. Lowitt and A. Szentivanyi, Depression of hepatic mixed-function oxidase activity by Bordetella pertussis in splenectomized and athymic nude mice, Immunopharmacology 3:101 (1981).

    Article  PubMed  CAS  Google Scholar 

  99. A. Szentivanyi and J. Szentivanyi, Neuester Stand der Rezeptoren-Theorie bei Atopie, Allergologie 6:155 (1983).

    Google Scholar 

  100. J.F. Williams and A. Szentivanyi, Continued studies on the effect of interferon inducers on the hepatic microsomal mixed-function oxidase system of rats and mice, J. Interferon Res. 3:211 (1983).

    Article  PubMed  CAS  Google Scholar 

  101. H. Friedman and A. Szentivanyi, Microbial vaccines — specific and non-specific modifiers of immunity, Immunol. Allergy Prac. 7:40/17 (1985).

    Google Scholar 

  102. J.F. Williams and A. Szentivanyi, Effect of carbon tetrachloride on hepatic cytochrome P-450 activity in endotoxin tolerant and polymixin B treated rats, The Pharmacologist 27:251 (1985).

    Google Scholar 

  103. J.F. Williams and A. Szentivanyi, Induction of tolerance in mice and rats to the effect of endotoxin to decrease the hepatic microsomal mixed-function oxidase system. Evidence for a possible macropahge-derived factor in endotoxin effect, Int. J. Immunopharmacol. 7:501 (1985).

    Article  PubMed  CAS  Google Scholar 

  104. H. Friedman and A. Szentivanyi, Antibacterial immunity, vaccines, and allergy, Allergologie 8:357 (1985).

    Google Scholar 

  105. H. Friedman, T. Klein, A. Szentivanyi and A. Nowotny, Immunomodulation by bacterial products: Role of intermediary soluble factors, Int. J. Immunother. 2:6164 (1986).

    Google Scholar 

  106. A. Nowotny, K. Blanchard, C. Newton, T.W. Klein, W. Stewart II, A. Szentivanyi and H. Friedman, Interferon induction by endotoxin-derived nontoxic polysaccharides, J. Interferon Res. 7:371 (1987).

    Article  PubMed  CAS  Google Scholar 

  107. A. Szentivanyi, S. Reiner, O. Heim, G. Filipp and C. Abarca, The effect of sympathetic ablation [6-hydroxydopamine hydrobromide (6-OHDA); axotomy] on endotoxin induced adrenergic mechanisms, The Pharmacologist 31:118 (1989).

    Google Scholar 

  108. A. Szentivanyi, S. Reiner, O. Heim, G. Filipp and C. Abarca, In vivo and in vitro studies on adrenergic mechanisms induced by Escherichia coli endotoxin, J. Leukocyte Biol. 46:328 (1989).

    Google Scholar 

  109. A. Szentivanyi, J.J. Krzanowski, J.B. Poison and C.M. Abarca, The pharmacology of microbial modulation in the induction and expression of immune reactivities. I. The pharmacologically active effector molecules of immunologic inflammation, immunity, and hypersensitivity, Immunopharmacol Rev. 1:159 (1990).

    Article  CAS  Google Scholar 

  110. J.F. Williams and A. Szentivanyi, Implications of hepatic drug metabolizing activity in the therapy of bronchial asthma, J. Allergy Clin. Immunol. 55:125 (1975).

    Google Scholar 

  111. S. Lowitt, J.F. Williams and A. Szentivanyi, Dexamethasone induction to tryptophan oxygenase activity in vivo and in isolated rat hepatic parenchymal cells: Effect of bacterial endotoxin, The Pharmacologist 20:157 (1978).

    Google Scholar 

  112. A. Szentivanyi and E. Middleton Jr., Asthma pharmacotherapy and why, J. Respirat. Therap. 1:10 (1980).

    Google Scholar 

  113. J.F. Hackney and A. Szentivanyi, Response of isolated guinea pig tracheal muscle to glucocorticoid and non-glucocorticoid succinates, Arch. Int. Pharmacodyn. Therap. 244:4 (1980).

    CAS  Google Scholar 

  114. L. Kirkman, A. Goldman, J.J. Krzanowski, J.B. Poison, W. Anderson, A. Richman and A. Szentivanyi, Enhanced in vitro sensitivity to propranolol-induced beta adrenergic blockade in COPD patients, Am. Rev. Resp. Dis. 123:79 (1981).

    Google Scholar 

  115. J.J. Krzanowski and A. Szentivanyi, Invited editorial: Reflections on some aspects of current research in asthma, J. Allergy Clin. Immunol. 72:433 (1983).

    Article  PubMed  CAS  Google Scholar 

  116. Y. Sakamoto, J.J. Krzanowski, R.F. Lockey, J.B. Poison and A. Szentivanyi, The potential of ergonovine to precipitate bronchial asthmatic attacks via serotonin receptors, J. Allergy Clin. Immunol. 73:129 (1984).

    Google Scholar 

  117. S. Robicsek, J.J. Krzanowski, J.B. Poison and A. Szentivanyi, Réévaluation of theophylline for asthma? J. Clin. Pharmacol. 29:859 (1989).

    Google Scholar 

  118. A. Szentivanyi, M.E. Schwartz, O. Heim and G. Filipp, Ketotifen and the N-formylmethionyl-leucyl-phenylalanine (FMLP) induced respiratory burst in asthma, Clin. Pharmacol. Therap. 47:137 (1990).

    Google Scholar 

  119. A. Szentivanyi, M.E. Schwartz, O. Heim, G. Filipp and C. Abarca, Ketotifen and the n-formylmethionyl-leucyl-phenylalanine (FMLP) induced respiratory burst in asthma, J. Clin. Pharmacol. 30:92 (1990).

    Article  Google Scholar 

  120. A. Szentivanyi, S. Reiner, O. Heim, C. Abarca, J. Szentivanyi, S. Robiecsek and J. Hackney, Impaired lymphokine regulation of b-adrenoceptors in asthma and atopic dermatitis, J. Leukocyte Biol. Suppl.1:183 (1990).

    Google Scholar 

  121. J. Szentivanyi, O. Heim, P. Schultze, H. Wagner, E.G. Calderón, R.F. Lockey, S. Robicsek and A. Szentivanyi, Similarities and differences in patterns of beta-adrenergic regulation by lymphocytic proteins in respiratory and cutaneous atopy versus cystic fibrosis, J. Allergy Clin. Immunol. 89:162 (1992).

    Google Scholar 

  122. A. Szentivanyi and D. F. Fitzpatrick, The altered reactivity of the effector cells to antigenic and pharmacological influences and its relation to cyclic nucleotides. II. Effector reactivities in the efferent loop of the immune response, in: “Pathomechanismmus und Pathogenese Allergischer Reaktionen,” G. Filipp, ed., Werk-Verlag Dr. Edmund Banachewski, Grafelfing bei München (1980).

    Google Scholar 

  123. A. Szentivanyi, J. B. Poison and J. J. Krzanowski, The altered reactivity of the effector cells to antigenic and pharmacological influences and its relation to cyclic nucleotides. I. Effector reactivities in the efferent loop of the immune response, in: “Pathomechanismus und Pathogenese Allergischer Reaktionen,” G. Filipp, ed., Werk-Verlag, Dr. Edmund Banachewski, Grafelfing bei München (1980).

    Google Scholar 

  124. A. Szentivanyi, J.J. Krzanowski, J.B. Poison and W. H. Anderson, Evolution of research strategy in the experimental analysis of the beta adrenergic approach to the constitutional basis of atopy, in: “Advances in Allergology and Clinical Immunology,” A. Oehling, E. Mathov, I. Glazer and C. Arbesman, eds., Pergamon Press, Oxford (1980).

    Google Scholar 

  125. A. Szentivanyi, Effect of bacterial products and adrenergic blocking agents on allergic reactions, in: “Textbook of Immunological Diseases,” M. Samter, D.W. Talmage, B. Rose, W.B. Sherman and J.H. Vaughan, eds., Little, Brown and Co., Boston, MA (1971).

    Google Scholar 

  126. A. Szentivanyi, J. J. Krzanowski and J. B. Poison, The autonomic nervous system: Structure, function, and altered effector responses, in: “Allergy: Principles and Practice,” E. Middleton, C. E. Reed and E. F. Ellis, eds., C.V. Mosby Co., St. Louis, MO (1978).

    Google Scholar 

  127. A. Szentivanyi and J. F. Williams, The constitutional basis of atopic disease, in: “Allergic Diseases of Infancy, Childhood, and Adolescence,” C. W. Bierman and D. S. Pearlman, eds., W.B. Saunders Co., Philadelphia, PA (1980).

    Google Scholar 

  128. A. Szentivanyi, Adrenergic and cholinergic receptor studies in human lung and lymphocytic membranes and their relation to bronchial hyperreactivity in asthma, in: “Patient Care Publications,” Darien, CT (1982).

    Google Scholar 

  129. A. Szentivanyi and J. Szentivanyi, Anti-allergic drugs and beta adrenoceptors, in: “Proceedings of the Congress of the European Academy of Allergology and Clinical Immunology,” Clermont-Ferrand, France (1982).

    Google Scholar 

  130. J.F. Hackney and A. Szentivanyi, The specificity of glucocorticoids in the relaxation of respiratory smooth muscle in vitro, J. Allergy Clin. Immunol. 55:123 (1975).

    Google Scholar 

  131. J.F. Hackney and A. Szentivanyi, The unique action of glucocorticoid succinates on respiratory smooth muscle in vitro, The Pharmacologist 17:271 (1975).

    Google Scholar 

  132. S. Lowitt, A. Szentivanyi and J.F. Williams, Endotoxin inhibition of dexamethasone induction of tryptophan oxygenase in suspension culture of isolated rat parenchymal cells. II. Effect of in vivo pretreatment of rats with endotoxin, Biochem. Pharmacol. 31:693 (1982).

    Google Scholar 

  133. A. Szentivanyi and J. Szentivanyi, Mechanisms of action of corticosteroids, in: “Proceedings of the International Symposium on Allergy and Immunoloty,” Lima, Peru (1985).

    Google Scholar 

  134. A. Szentivanyi, The immune-neuroendocrine circuitry~The next, and possibly, the last frontier of vertebrate immunity, in: I. Berczi and J. Szelenyi, eds., “Advances in Psychoneuroimmunology,” Plenum Press (1994).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology, University of Manitoba, Winnipeg, Manitoba, R3E 0W3, Canada

    Istvan Berczi

Authors
  1. Istvan Berczi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Immunology, The University of Manitoba, Winnipeg, Manitoba, Canada

    Istvan Berczi

  2. National Institute of Haematology, Blood Transfusion and Immunology, Budapest, Hungary

    Judith Szélenyi

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Berczi, I. (1994). Neural Regulation of Allergy and Asthma. The Discoveries and Seminal Contributions of Andor Szentivanyi. In: Berczi, I., Szélenyi, J. (eds) Advances in Psychoneuroimmunology. Hans Selye Symposia on Neuroendocrinology and Stress, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9104-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9104-4_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9106-8

  • Online ISBN: 978-1-4757-9104-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation